Over the years, great improvements have been witnessed in the field of medicine. The research and knowledge on oncogenes have been undertaken and gathered and has been an important resource in the field of oncology and other closely related fields. Oncology is rapidly becoming an area of interest due to its complexity. Luckily, Oncologists like Mikhail Blagosklonny have simplified this discipline by translating this complex research to simple information that can be readily utilized in clinical settings.
Oncotarget is a medical journal published weekly under the review of medical peers. It is wide and has extensive coverage on oncology. It was brought to life in 2010 under the Impact Journal Publishers. The journal has two figureheads, Mikhail Blagosklonny and Andrei V. Gudkov, both from Roswell Park Cancer Institute and more information click here.
The journal focuses on cancer treatments. Majorly, it specializes in the pathology of all cancers, target therapy, and the procedure involved in the management of cancer patients. Moreover, it is set on reviewing the impact of the instituted management programs, the emerging therapies and protocols on patients. In simple terms, Oncotarget concentrates on improving the results of cancer treatments in the eyes of both the patients and medical professionals. It is a famed-universal medical journal that is globally renowned for its on-time, encouraging, and building reviews that work to assist researchers in the depth of their studies on cancer. Also, it helps its readers to live a quality and stress-free life. Patients and health service providers are vastly informed on the new therapies, how they work, and ways of assisting new patients to live better lives by accepting their condition and learn more about Oncotarget.
Oncotarget addresses diverse issues and is not entirely focused on oncology. It is gaining popularity due to the fact that it is currently breaking boundaries to cover other equally important topics on human anatomy. Besides, it is known to publish papers on cell biology, cardiology, metabolism, neuroscience, and other significant disciplines and Oncotarget on Facebook.
The journal has overtime enjoyed tremendous growth and attained admirable achievements. For starters, since the commencement of its operations, four of its members have received the Breakthrough Prize, an accolade considered as the highest prize in this line of work. It has a very high impact, which is evidenced by the increased number of its citations and Oncotarget’s lacrosse camp.